Novo Nordisk A/S ADR (NVO) Stock Price, Quote & News

Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products i...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 45 44 44 88 88

Website: www.novonordisk.com

Address:

Novo Alle 1, Bagsvaerd, Denmark

JacoI3 Nov. 14 at 11:20 AM

$NVO https://pubmed.ncbi.nlm.nih.gov/40285721/

0 · Reply

theirishreally Nov. 14 at 10:27 AM

$NVO Novo’s new multi-billion-euro bond sale was nearly 5x oversubscribed—massive! Big money (think pension funds, insurers, sovereigns) lined up because they trust Novo’s cash flow and long-term stability, even with the Akero deal in play. Bond buyers aren’t gamblers—they want safety, and Novo looks ultra-solid. Oversubscription like this means institutions see Novo as one of Europe’s safest bets, despite raising debt for new growth. If risk-averse investors love it, that’s a powerful vote of confidence for both the Akero acquisition and Novo’s leadership in GLP-1. Retail might stress on red days, but the pros are signalling long-term strength!

1 · Reply

Europlus Nov. 14 at 10:05 AM

$NVO the whole pre is so fucking brutal🙄 everything got hit. My Watchlist is a Desaster😆. I will Take a Look next week. Bye.

1 · Reply

NorthstarT1D Nov. 14 at 10:04 AM

$NVO extraordinary general meeting today. Dramatic media articles claiming there's going to be a big fight, but the foundation has 70%+ of the voting rights, so it will be brief and decisive. Let's get this over with.

0 · Reply

Wolli1976 Nov. 14 at 9:59 AM

$NVO

0 · Reply

Wolli1976 Nov. 14 at 9:45 AM

$NVO I told you before 38-42$ target

1 · Reply

Pf89 Nov. 14 at 9:24 AM

$NVO trailing stop kicked in , what tf.

0 · Reply

StocktwitsNews Nov. 14 at 9:18 AM

Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO $NVO $MTSR $PFE $LLY https://stocktwits.com/news/equity/markets/novo-nordisk-stock-falls-premarket-as-investors-brace-for-contentious-vote-to-reinstate-former-ceo/cLPQdm5REEu

0 · Reply

LiquidThetaOptions Nov. 14 at 9:00 AM

💎 LiquidTheta® Live Actionable Trade Asset: $NVO Contracts: $NVO December 18, 2026 $50 Calls Scale in: $9.16- $11.20 Scale out: $35.62-$61.06 Profit Potential : 330% ROI Blended Join 💎 Here: https://liquidtheta.com

0 · Reply

MoneyGroupLLC Nov. 14 at 7:39 AM

Enter: $NVO Calls Strike Price: $50 Expiry Date: DEC 05 2025 Buy in Price: $2.62 - $2.79 Sell Price: $4.30 Profit : +64% (Turn every $1 into $1.64) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

Novo Nordisk's leadership strategy tested as shareholders signal frustration ahead of vote on board revamp

Nov 14, 2025, 3:30 AM EST - 4 hours ago

Novo Nordisk Says Mikael Dolsten Won't Seek Election to Board at Friday's Meeting

Nov 13, 2025, 6:19 PM EST - 13 hours ago

Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race

PFE

Nov 13, 2025, 5:44 PM EST - 13 hours ago

Novo: The Double Bottom Is In

Nov 13, 2025, 5:38 PM EST - 13 hours ago

Novo Nordisk A/S: Candidate for the Board of Directors will not seek election

Nov 13, 2025, 2:32 PM EST - 17 hours ago

Novo Nordisk: Long-Term Brand Dominance At A Bargain

Nov 13, 2025, 2:04 PM EST - 17 hours ago

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

LLY MGRX

Nov 13, 2025, 10:33 AM EST - 21 hours ago

'Not been pretty': Novo Nordisk faces rare shareholder rebuke over board shake-up

Nov 13, 2025, 7:15 AM EST - 1 day ago

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

LLY MGRX

Nov 12, 2025, 10:05 PM EST - 1 day ago

Novo Nordisk: Reliable Weigh-Loss Growth Story With More Upside Than Bears Admit

Nov 12, 2025, 3:06 PM EST - 1 day ago

Novo Nordisk CEO signals new appetite for risk in obesity deals

Nov 12, 2025, 2:04 PM EST - 1 day ago

WeightWatchers to sell Novo Nordisk's Wegovy pill after 2026 launch

Nov 12, 2025, 11:43 AM EST - 1 day ago

Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data

Nov 11, 2025, 12:35 PM EST - 2 days ago

Novo Nordisk: Consider The Counterfactual

Nov 11, 2025, 11:55 AM EST - 2 days ago

Virtus SGA International Growth Q3 2025 Portfolio Activity

BABA

Nov 11, 2025, 10:25 AM EST - 2 days ago

GLP-1 prices are dropping: Who exactly will benefit?

LLY

Nov 11, 2025, 9:52 AM EST - 2 days ago

Why Novo Nordisk slashed prices of its weight-loss drug in India: 5 key points

Nov 11, 2025, 8:42 AM EST - 2 days ago

Exclusive: Novo Nordisk cuts Wegovy price by up to 33% in India, document shows

Nov 10, 2025, 5:28 PM EST - 3 days ago

Novo Nordisk: Buy This Bargain

Nov 10, 2025, 7:32 AM EST - 4 days ago

Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Winner.

MTSR PFE

Nov 10, 2025, 4:38 AM EST - 4 days ago

Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle

MTSR

Nov 10, 2025, 3:45 AM EST - 4 days ago

U.S. Senate Makes Progress on Shutdown Deal, Novo Nordisk Loses Out to Pfizer

PFE

Nov 10, 2025, 3:05 AM EST - 4 days ago

Novo Nordisk shares rise after dropping Metsera bid

MTSR

Nov 10, 2025, 2:37 AM EST - 4 days ago

Norway's sovereign wealth fund to abstain from Novo Nordisk board vote

Nov 10, 2025, 1:04 AM EST - 4 days ago

Novo Nordisk to sell weight loss drug Poviztra in India

Nov 9, 2025, 1:01 PM EST - 4 days ago

Virtus SGA Global Growth Q3 2025 Portfolio Positioning

BABA CMG IT NOW SAP UNH WDAY

Nov 9, 2025, 9:00 AM EST - 4 days ago

Novo Nordisk: Hold On Tightly As The Market Tests Your Faith

Nov 8, 2025, 3:19 AM EST - 6 days ago

Novo Nordisk will not increase its proposal to acquire Metsera, Inc.

MTSR

Nov 7, 2025, 3:29 PM EST - 6 days ago

Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk

LLY

Nov 7, 2025, 11:49 AM EST - 6 days ago

Eli Lilly, Novo Nordisk's Historic GLP-1 Pricing Deals - What Investors Need To Know

LLY

Nov 7, 2025, 3:34 AM EST - 7 days ago

Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE

Nov 7, 2025, 3:23 AM EST - 7 days ago

Novo Nordisk shares fall after deal with Trump to slash obesity drug prices

Nov 6, 2025, 4:39 PM EST - 7 days ago

Lily, Novo cut prices on Wegovy and Zepbound in exchange for deal on tariffs

LLY

Nov 6, 2025, 3:30 PM EST - 7 days ago

Eli Lilly and Novo Nordisk lower GLP-1 drug costs in new deal with Trump.

LLY

Nov 6, 2025, 2:42 PM EST - 7 days ago

Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk

LLY

Nov 6, 2025, 2:36 PM EST - 7 days ago

Novo Nordisk's experimental obesity drug CagriSema shows blood pressure benefits

Nov 6, 2025, 2:30 PM EST - 7 days ago

Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®

Nov 6, 2025, 2:23 PM EST - 7 days ago

Novo CEO says its bid for Metsera is higher

MTSR

Nov 6, 2025, 2:10 PM EST - 7 days ago

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

LLY

Nov 6, 2025, 1:23 PM EST - 7 days ago

Novo Nordisk expects global sales to decline by low single digits in 2026

Nov 6, 2025, 1:02 PM EST - 7 days ago

Lilly, Novo Will Lower Obesity Drug Prices in Trump Deal

LLY

Nov 6, 2025, 1:01 PM EST - 7 days ago

Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost

Nov 6, 2025, 12:49 PM EST - 7 days ago

President Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices

LLY

Nov 6, 2025, 12:39 PM EST - 7 days ago

Trump strikes deal with Eli Lilly, Novo Nordisk to cut GLP-1 weight-loss drug prices

LLY

Nov 6, 2025, 12:04 PM EST - 7 days ago

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

LLY

Nov 6, 2025, 12:04 PM EST - 7 days ago

Trump White House confirms pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk

LLY

Nov 6, 2025, 12:01 PM EST - 7 days ago

What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?

MTSR PFE

Nov 6, 2025, 6:29 AM EST - 8 days ago

Wall Street Breakfast Podcast: Government Shutdown Hits New Altitude

MTSR PFE WBD

Nov 5, 2025, 6:21 PM EST - 8 days ago

Novo Nordisk A/S (NVO) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:52 PM EST - 8 days ago

Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk

MTSR PFE

JacoI3 Nov. 14 at 11:20 AM

$NVO https://pubmed.ncbi.nlm.nih.gov/40285721/

0 · Reply

theirishreally Nov. 14 at 10:27 AM

1 · Reply

Europlus Nov. 14 at 10:05 AM

$NVO the whole pre is so fucking brutal🙄 everything got hit. My Watchlist is a Desaster😆. I will Take a Look next week. Bye.

1 · Reply

NorthstarT1D Nov. 14 at 10:04 AM

0 · Reply

Wolli1976 Nov. 14 at 9:59 AM

$NVO

0 · Reply

Wolli1976 Nov. 14 at 9:45 AM

$NVO I told you before 38-42$ target

1 · Reply

Pf89 Nov. 14 at 9:24 AM

$NVO trailing stop kicked in , what tf.

0 · Reply

StocktwitsNews Nov. 14 at 9:18 AM

0 · Reply

LiquidThetaOptions Nov. 14 at 9:00 AM

0 · Reply

MoneyGroupLLC Nov. 14 at 7:39 AM

0 · Reply

kollsbull Nov. 14 at 7:38 AM

$NVO money should flow into this quality beaten down stock now with market in red.

0 · Reply

HedgeAlerts Nov. 14 at 7:09 AM

Hedge Alert Live - Protect Your Portfolio Contract: $NVO $49.00 Put · NOV 21, 2025 Exp Entry Price: $1.86 - $1.94 Exit Price Target: $2.94 Profit Margin: +58% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

Europlus Nov. 14 at 6:59 AM

$NVO Always keep in mind that we have a good Chance of a great catalyst when the announce the PILL😁 No Financial advice

0 · Reply

Venky_clt Nov. 14 at 5:30 AM

$NVO Despite entire market crash this held strong. Not sure where this will be next year after $LLY journey.

0 · Reply

OptionsJohnny Nov. 14 at 2:38 AM

$NVO: watching for a new pattern here; hopefully a bullish pattern.

0 · Reply

EmbraceVolatility Nov. 14 at 1:12 AM

$NVO Guess the games aren't over. Ill let my $49 put ride.

0 · Reply

TalkMarkets Nov. 14 at 12:06 AM

#AI Frenzy: Everybody Wants #NVIDIA's Magical #GPUs $NVO $INTC $NVDA https://talkmarkets.com/content/stocks--equities/ai-frenzy-everybody-wants-nvidias-magical-gpus?post=536949

0 · Reply

tylero2 Nov. 13 at 10:20 PM

$NVO misinformation at its finest. Selectively leaving out some key information: 1. This is in the Indian market 2. NVO entered the Indian market in June while Lily entered in March.

2 · Reply

Bombay55 Nov. 13 at 10:08 PM

$NVO bad press unfortunately

1 · Reply

QuantInsider Nov. 13 at 10:08 PM

What's up with $NVO today? Down 2.19% but no fresh catalysts Makes you wonder if it's just a dip Spotted a $605K ask-side sweep in Feb 2026 $50 calls on InsiderFinance That's some serious upside positioning with time to play out Keeps the 5D bias constructive but I’d wait for price to stabilize before jumping in Today’s action includes four call sweeps in 11/21 $60S Around 20% OTM Only ~$81K premium at ~84% IV Looks like some speculative nibbling If you're thinking of joining, maybe consider defined-risk call spreads instead of going naked Keep an eye on the price action for a bit

0 · Reply

stockswinger14 Nov. 13 at 10:00 PM

$NVO very

0 · Reply

SqueezingGame Nov. 13 at 9:51 PM

$GOOGL $AVGO $QUBT $NVO 🌴

0 · Reply

Market Cap	224.41B
Revenue (ttm)	42.11B
Net Income (ttm)	14.64B
EPS (ttm)	N/A
PE Ratio	12.87
Forward PE	13.55
Profit Margin	34.78%
Debt to Equity Ratio	0.60

Volume	18,878,300
Avg Vol	15,734,562
Day's Range	N/A - N/A
Shares Out	4.47B
Stochastic %K	76%
Beta	0.65
Analysts	Sell
Price Target	$54.40